VINTESOMERAN
UNII 3E9P89C6JX

Substance Identification & Data

This profile provides standardized clinical and technical data for Vintesomeran, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3E9P89C6JX.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2923391-66-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

3E9P89C6JX

CAS Registry Number

2923391-66-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

VINTESOMERAN

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C203096

National Cancer Institute reference terminology for clinical and research data.

INN ID

13098

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

nucleicAcid

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Vintesomeran. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

VINTESOMERAN

Common Names & Synonyms

CX-040631 (COVID-19 OMICRON VARIANT XBB.1.16)

CX-040631 OMICRON (XBB.1.16)

MESSENGER RNA (MRNA), 5'-CAPPED, ENCODING A FULL-LENGTH, CODON-OPTIMISED PRE-FUSION STABILISED CONFORMATION VARIANT (K982P AND V983P) OF THE SARS-COV-2 (SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2) SPIKE (S)GLYCOPROTEIN (OMICRON VARIANT XBB.1.16; BASED UPON GISAID:EPI_ISL_16835403) FURTHER OPTIMIZED BY TWO ADDITIONAL STOP CODONS, FLANKED BY AN ARTIFICIAL 5' UNTRANSLATED REGION (UTR) AND A 3' UTR DERIVED FROM THE HUMAN ALPHA GLOBIN GENE (HBA1) MODIFIED TO CONTAIN AN IDENTIFICATION AND RATIO (IDR) SEQUENCE TO ENABLE IDENTIFICATION AND RELATIVE RATIO DETERMINATION OF INDIVIDUAL RNA COMPONENTS IN A MULTIVALENT MRNA VACCINE, AND TERMINATED BY A 3' POLYADENYLATION (POLYA) TAIL; CONTAINS N1-METHYLPSEUDOURIDINE INSTEAD OF URIDINE (ALL-U>M 1.PSI.)

RNA (RECOMBINANT 5'-(M7G-(5'->5')-PPP-GM)-CAPPED ALL URIDINE->N1-METHYLPSEUDOURIDINE-SUBSTITUTED SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 PRE-FUSION SPIKE GLYCOPROTEIN (982-PROLINE,983-PROLINE) XBB.1.16 VARIANT PLUS 5'- AND 3'-UNTRANSLATED FLANKING REGION-CONTAINING POLY(A)-TAILED MESSENGER CX-040631), INNER SALT

VINTESOMERAN [INN]

Technical Codes

CX-040631

External Clinical & Regulatory Resources

Previous UNII3E9C84Q228

Next UNII3E9T80FR85